Accordingly, GBM patient tumors showed areas with and without LDs, and LD-positive cells resided in the hypoxic tumor niche, as indicated by co-staining for the hypoxia marker GLUT-1 ((Fig. 1b). Here, SLC2A1 is linked to neoplasm.